Beijing Beilu Pharmaceutical Co (SZSE:300016) Long-Term Debt : ¥705 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Long-Term Debt?

Beijing Beilu Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2025 was ¥705 Mil.

Beijing Beilu Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2024 (¥632 Mil) to Dec. 2024 (¥600 Mil) but then increased from Dec. 2024 (¥600 Mil) to Mar. 2025 (¥705 Mil).

Beijing Beilu Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2022 (¥516 Mil) to Dec. 2023 (¥593 Mil) and increased from Dec. 2023 (¥593 Mil) to Dec. 2024 (¥600 Mil).

Beijing Beilu Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Long-Term Debt Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

553.18

476.10

516.28

592.55

600.24

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Debt	Get a 7-Day Free Trial															623.99	631.60	631.76	600.24	704.88

Beijing Beilu Pharmaceutical Co (SZSE:300016) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Beijing Beilu Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines